JPS60173470A - 低密度のリポ蛋白質を測定する方法及び試薬 - Google Patents

低密度のリポ蛋白質を測定する方法及び試薬

Info

Publication number
JPS60173470A
JPS60173470A JP59223130A JP22313084A JPS60173470A JP S60173470 A JPS60173470 A JP S60173470A JP 59223130 A JP59223130 A JP 59223130A JP 22313084 A JP22313084 A JP 22313084A JP S60173470 A JPS60173470 A JP S60173470A
Authority
JP
Japan
Prior art keywords
cholesterin
antibody
hdl
reagent
ldl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59223130A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0235260B2 (enExample
Inventor
ロレンツ・ケルシヤー
ヨアヒム・ツイーゲンホルン
ジークベルト・シーフアー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPS60173470A publication Critical patent/JPS60173470A/ja
Publication of JPH0235260B2 publication Critical patent/JPH0235260B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP59223130A 1983-10-26 1984-10-25 低密度のリポ蛋白質を測定する方法及び試薬 Granted JPS60173470A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833338836 DE3338836A1 (de) 1983-10-26 1983-10-26 Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
DE3338836.9 1983-10-26

Publications (2)

Publication Number Publication Date
JPS60173470A true JPS60173470A (ja) 1985-09-06
JPH0235260B2 JPH0235260B2 (enExample) 1990-08-09

Family

ID=6212769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59223130A Granted JPS60173470A (ja) 1983-10-26 1984-10-25 低密度のリポ蛋白質を測定する方法及び試薬

Country Status (5)

Country Link
US (1) US4746605A (enExample)
EP (1) EP0141343B1 (enExample)
JP (1) JPS60173470A (enExample)
AT (1) ATE34848T1 (enExample)
DE (2) DE3338836A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6264956A (ja) * 1985-09-18 1987-03-24 Teijin Ltd 肺表面活性物質の検出方法及びそれに用いる試薬キツト
JPS62211554A (ja) * 1986-03-12 1987-09-17 Teijin Ltd ヒトの肺表面活性物質の測定方法
JPS63501037A (ja) * 1985-09-27 1988-04-14 フア−マシア・ア−・ベ− リポタンパク質及びアポリポタンパク質の測定方法
JP2019066270A (ja) * 2017-09-29 2019-04-25 コニカミノルタ株式会社 測定用抗体分散液、その製造方法、測定用抗体分散液調製用キット、および生体物質測定方法

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751182T2 (de) * 1986-08-06 1995-10-26 Scripps Clinic Res Monoklonale Antikörper, B-spezifisch für Apolipoprotein, die von zwei Hybridomen erzeugt werden.
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
NL8602869A (nl) * 1986-11-12 1988-06-01 Univ Utrecht Werkwijze voor het aantonen, identificeren en/of kwantificeren van circulerende immuuncomplexen in bloedserum.
US5057226A (en) * 1988-05-18 1991-10-15 Cobe Laboratories, Inc. Treatment of liquid including blood components
US4968432A (en) * 1988-05-18 1990-11-06 Cobe Laboratories, Inc. Treatment of liquid including blood components
DE3817747A1 (de) * 1988-05-25 1989-11-30 Johannes Dr Med Aufenanger Verfahren zum bestimmen der relativen mengen aller cholesterinhaltigen lipoproteine in koerperfluessigkeiten
EP0380633A4 (en) * 1988-07-11 1990-12-05 East Tennessee State University Arteriosclerosis prognostication procedure and therapeutic method
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
US5275952A (en) * 1989-01-23 1994-01-04 Reanal Finomveygszergyar Analytical method for the selective determination of sialic glycolipid complexes
USRE39915E1 (en) 1989-09-01 2007-11-06 Roche Diagnostics Gmbh Method for the determination of HDL cholesterol by means of a rapid diagnostic agent with an integrated fractionating step
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
US5149501A (en) * 1990-01-29 1992-09-22 Cirrus Diagnostics, Inc. Multichambered container and instrument for performing diagnostic tests
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
US5783400A (en) * 1990-04-27 1998-07-21 Genzyme Corporation Method for the isolation of lipoprotein allowing for the subsequent quantification of its mass and cholesterol content
US5168067A (en) * 1990-05-25 1992-12-01 Miller Michael A Method and kit for screening for apolipoprotein b or calculated ldl cholesterol
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
EP0559795B1 (en) * 1990-11-30 1995-12-27 Monoclonetics International, Inc. Methods for the diagnosis of chronic lower back and cervical pain
US5286626A (en) * 1991-12-13 1994-02-15 Actimed Laboratories, Inc. Process and apparatus for direct determination of low density lipoprotein
JP2920044B2 (ja) * 1993-05-12 1999-07-19 克昌 小池 水溶性酸化脂質の生成方法及び酸化脂質の確認・測定方法
US5561052A (en) * 1992-06-18 1996-10-01 Koike; Katsumasa Process for detecting oxidized lipids and process for forming oxidized lipids
US5460974A (en) * 1992-10-13 1995-10-24 Miles Inc. Method of assaying whole blood for HDL cholesterol
US5290703A (en) * 1992-12-14 1994-03-01 Miles, Inc. Method for the separation of high density lipoprotein from blood samples
AU3151495A (en) * 1994-08-01 1996-03-04 James T Hsu Lipoprotein cholesterol assays
US5962340A (en) * 1994-11-02 1999-10-05 Wako Pure Chemical Industries Ltd. Homogeneous immunoassay method utilizing 5-300 mM magnesium
JP2799835B2 (ja) * 1995-01-31 1998-09-21 第一化学薬品株式会社 コレステロールの定量方法
EP1650569A3 (en) * 1995-03-16 2006-05-17 Kyowa Medex Co., Ltd. Method for determination of cholesterol in low-density lipoprotein
ES2165947T3 (es) * 1995-07-21 2002-04-01 Wako Pure Chem Ind Ltd Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica.
JP3441993B2 (ja) * 1999-01-27 2003-09-02 松下電器産業株式会社 コレステロールセンサ
CN1187609C (zh) 1999-11-22 2005-02-02 松下电器产业株式会社 胆固醇传感器和胆固醇的定量方法
US6898728B2 (en) * 2001-09-25 2005-05-24 Sun Microsystems, Inc. System domain targeted, configurable interconnection
US6753185B2 (en) * 2001-10-01 2004-06-22 The Texas A&M University System Lipoprotein fingerprinting method
ES2252358T3 (es) * 2002-04-09 2006-05-16 Cholestech Corporation Metodo y dispositivo de ensayo para la cuantificacion del colesterol asociado a lipoproteinas de alta densidad.
US7772007B2 (en) * 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
US7491542B2 (en) * 2004-07-12 2009-02-17 Kim Scheuringer Test device for determining the concentration of LDL-cholesterol in a sample
WO2008086019A1 (en) * 2007-01-09 2008-07-17 Cholestech Corporation Device and method for measuring ldl-associated cholesterol
CN104356227B (zh) * 2014-11-11 2020-05-22 浙江蓝怡医药有限公司 血清脂类、脂蛋白及载脂蛋白高效浓缩提取方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884764A (en) * 1974-03-25 1975-05-20 Eastman Kodak Co Method and composition for blood serum cholesterol analysis
US4018662A (en) * 1975-01-03 1977-04-19 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method and apparatus for simultaneous quantitative analysis of several constituents in a sample
DE2612725C3 (de) * 1976-03-25 1979-05-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagenz zur Bestimmung von Cholesterin
NL7701800A (nl) * 1977-02-18 1978-08-22 Akzo Nv Testkit en methode voor de bepaling van lp-x.
FR2455743A1 (fr) * 1979-05-02 1980-11-28 Goella Laboratoires Procede et dispositif pour le dosage des lipoproteines seriques
JPS57103057A (en) * 1980-12-19 1982-06-26 Meito Sangyo Kk Automatic measuring method for hdl-cholesterol and its precipitant
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6264956A (ja) * 1985-09-18 1987-03-24 Teijin Ltd 肺表面活性物質の検出方法及びそれに用いる試薬キツト
JPS63501037A (ja) * 1985-09-27 1988-04-14 フア−マシア・ア−・ベ− リポタンパク質及びアポリポタンパク質の測定方法
JPS62211554A (ja) * 1986-03-12 1987-09-17 Teijin Ltd ヒトの肺表面活性物質の測定方法
JP2019066270A (ja) * 2017-09-29 2019-04-25 コニカミノルタ株式会社 測定用抗体分散液、その製造方法、測定用抗体分散液調製用キット、および生体物質測定方法

Also Published As

Publication number Publication date
ATE34848T1 (de) 1988-06-15
EP0141343A3 (en) 1986-07-09
JPH0235260B2 (enExample) 1990-08-09
DE3338836A1 (de) 1985-05-09
DE3471758D1 (en) 1988-07-07
EP0141343B1 (de) 1988-06-01
US4746605A (en) 1988-05-24
EP0141343A2 (de) 1985-05-15

Similar Documents

Publication Publication Date Title
JPS60173470A (ja) 低密度のリポ蛋白質を測定する方法及び試薬
US5407836A (en) Process and reagent for the determination of low density lipoproteins (LDL)
Sellers et al. The binding of smooth muscle myosin light chain kinase and phosphatases to actin and myosin.
DE69126664T2 (de) Bestimmung von analyten in biologischen flüssigkeiten in gegenwart von störenden substanzen
Vijayagopal et al. Interaction of serum lipoproteins and a proteoglycan from bovine aorta.
Cardenas et al. Bovine Pyruvate Kinases: I. PURIFICATION AND CHARACTERIZATION OF THE SKELETAL MUSCLE ISOZYME
US4110077A (en) Determination of β-lipoproteins in blood serum with polyanethole sulfonate
Moschides et al. Isolation and purification of the clearing factor of postheparin human plasma
Jakoi et al. Regular structures in unit membranes. II. Morphological and biochemical characterization of two water-soluble membrane proteins isolated from the suckling rat ileum.
US4210557A (en) Non-high density lipoprotein precipitant
Shore et al. Some physical and chemical properties of the lipoproteins produced by lipolysis of human serum Sf 20–400 lipoproteins by post-heparin plasma
Soutar et al. The characterization of lipoproteins in the high density fraction obtained from patients with familial lecithin: cholesterol acyltransferase deficiency and their interaction with cultured human fibroblasts.
Zittle et al. The fat-globule membrane of milk: Alkaline phosphatase and xanthine oxidase in skimmilk and cream
EP1169647B1 (en) Method for analyzing the amount of intraabdominal adipose tissue
WO1996004556A1 (en) Lipoprotein cholesterol assays
Maslamani et al. Changes in urine macromolecular composition during processing
Ilhan et al. Localization and characterization of the novel protein encoded by C20orf3
JP3869471B2 (ja) Ｈｄｌコレステロールの特異的測定方法及び測定用組成物
Pan et al. Binding of [3H] heparin to human plasma low density lipoprotein
US5783400A (en) Method for the isolation of lipoprotein allowing for the subsequent quantification of its mass and cholesterol content
JP3694121B2 (ja) Ｈｄｌコレステロールの特異的測定用組成物及び測定方法
US5614414A (en) Liquid lipoprotein control
Rosenblum et al. Granulocyte alkaline phosphatase. Studies of purified enzymes from normal subjects and patients with polycythemia vera
Walter et al. Differential electrophoretic behavior in aqueous polymer solutions of red blood cells from Alzheimer patients and from normal individuals
CN114487407A (zh) 一种血管紧张素转化酶2的检测试剂盒